Drugs / DTPa-IPV/Hib vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00880477 | Jan 2001 → Nov 2002 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-IPV/Hib vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00880477 ↗ |
| Modality | Vaccine | “Biological: DTPa-IPV/Hib vaccine” NCT00880477 ↗ |